News, press, and scientific dialogue.
Selected announcements, media coverage, and upcoming conference presentations from the Kihealth Labs team.
May 2026
Press Release
Kihealth Labs announces $120M Series C to advance InterceptIQ™ platform
Mar 2026
Press Release
BetaIntercept™ T1 enrolls 4,000th participant in pivotal validation study
Feb 2026
Press Release
Kihealth Labs and major pharmaceutical partner expand companion-diagnostic agreement
Nov 2025
Press Release
Kihealth Labs receives FDA Breakthrough Device designation for OncoIntercept™
Apr 2026 · Endpoints News
The next frontier in liquid biopsy isn't cancer — it's beta cells
Mar 2026 · STAT
Disease interception: the diagnostics thesis behind Kihealth Labs
Jan 2026 · Nature Biotechnology
How federated AI is changing biomarker discovery
Jun 2026
BetaIntercept™ T1: Pivotal validation interim readout
ADA Scientific Sessions
Sep 2026
Methylation atlas v3 — tissue-of-origin at 47 cell types
ASHG Annual Meeting
Oct 2026
OncoIntercept™ in stage I PDAC surveillance
ESMO Congress